Caminero, José A .García-Basteiro, Alberto L.Rendon, Adrian2019-09-232019-09-232019-07-270140-6736https://hdl.handle.net/2445/140760The ideal number of drugs needed and treatment duration are crucial issues in the management of multidrug-resistant tuberculosis (MDR-TB). Thus, we read with interest the Article by the Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017,1 the results of which support our proposal,2 from 2015, to classify anti-tuberculosis drugs on the basis of their toxicity, and sterilising or bactericidal activity.1 p.application/pdfeng(c) Elsevier, 2019TuberculosiResistència als medicamentsTuberculosisDrug resistanceinfo:eu-repo/semantics/article2019-08-09info:eu-repo/semantics/openAccess23190229